Magnetic Resonance Texture Analysis in Alzheimer's disease

被引：41

作者：

Cai, Jia-Hui ^{[1
]}

He, Yuan ^{[1
]}

Zhong, Xiao-Lin ^{[2
]}

Lei, Hao ^{[1
]}

Wang, Fang ^{[1
]}

Luo, Guang-Hua ^{[1
]}

Zhao, Heng ^{[1
,3
]}

Liu, Jin-Cai ^{[1
]}

机构：

[1] Univ South China, Dept Radiol, Affiliated Hosp 1, Chuanshan Rd 69, Hengyang 421000, Hunan, Peoples R China

[2] Univ South China, Inst Clin Med, Affiliated Hosp 1, Hengyang, Hunan, Peoples R China

[3] China Med Univ, Dept Radiol, Shengjing Hosp, Sanhao St 36, Shenyang 110004, Peoples R China

来源：

ACADEMIC RADIOLOGY | 2020年 / 27卷 / 12期

关键词：

Alzheimer's disease; Magnetic Resonance Imaging; Texture Analysis; Machine learning; MILD COGNITIVE IMPAIRMENT; AMYLOID-BETA PEPTIDE; OXIDATIVE STRESS; MRI; DIAGNOSIS; DEMENTIA; IMAGES; INFLAMMATION; PREVENTION; RADIOMICS;

D O I：

10.1016/j.acra.2020.01.006

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Texture analysis is an emerging field that allows mathematical detection of changes in MRI signals that are not visible among image pixels. Alzheimer's disease, a progressive neurodegenerative disease, is the most common cause of dementia. Recently, multiple texture analysis studies in patients with Alzheimer's disease have been performed. This review summarizes the main contributors to Alzheimer's disease-associated cognitive decline, presents a brief overview of texture analysis, followed by review of various MR imaging texture analysis applications in Alzheimer's disease. We also discuss the current challenges for widespread clinical utilization. MR texture analysis could potentially be applied to develop neuroimaging biomarkers for use in Alzheimer's disease clinical trials and diagnosis.

引用

页码：1774 / 1783

页数：10

共 71 条

[31] Origin and differentiation of microglia [J].

Ginhoux, Florent ;

Lim, Shawn ;

Hoeffel, Guillaume ;

Low, Donovan ;

Huber, Tara .

FRONTIERS IN CELLULAR NEUROSCIENCE, 2013, 7

[32] eDoctor: machine learning and the future of medicine [J].

Handelman, G. S. ;

Kok, H. K. ;

Chandra, R. V. ;

Razavi, A. H. ;

Lee, M. J. ;

Asadi, H. .

JOURNAL OF INTERNAL MEDICINE, 2018, 284 (06) :603-619

[33] Review: Clinical, neuropathological and genetic features of Lewy body dementias [J].

Hansen, D. ;

Ling, H. ;

Lashley, T. ;

Holton, J. L. ;

Warner, T. T. .

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2019, 45 (07) :635-654

[34] Predicting MCI outcome with clinically available MRI and CSF biomarkers [J].

Heister, D. ;

Brewer, J. B. ;

Magda, S. ;

Blennow, K. ;

McEvoy, L. K. .

NEUROLOGY, 2011, 77 (17) :1619-1628

[35] Texture Analysis: A Review of Neurologic MR Imaging Applications [J].

Kassner, A. ;

Thornhill, R. E. .

AMERICAN JOURNAL OF NEURORADIOLOGY, 2010, 31 (05) :809-816

[36]

Kodama N, 2009, WORLD C MED PHYS BIO

[37] Three-dimensional texture analysis of MRI brain datasets [J].

Kovalev, VA ;

Kruggel, F ;

Gertz, HJ ;

von Cramon, DY .

IEEE TRANSACTIONS ON MEDICAL IMAGING, 2001, 20 (05) :424-433

[38] The Diagnosis and Management of Mild Cognitive Impairment A Clinical Review [J].

Langa, Kenneth M. ;

Levine, Deborah A. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (23) :2551-2561

[39] The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis [J].

Leijenaar, Ralph T. H. ;

Nalbantov, Georgi ;

Carvalho, Sara ;

van Elmpt, Wouter J. C. ;

Troost, Esther G. C. ;

Boellaard, Ronald ;

Aerts, Hugo J. W. L. ;

Gillies, Robert J. ;

Lambin, Philippe .

SCIENTIFIC REPORTS, 2015, 5

[40] Mitochondria- and Oxidative Stress-Targeting Substances in Cognitive Decline-Related Disorders: From Molecular Mechanisms to Clinical Evidence [J].

Lejri, Imane ;

Agapouda, Anastasia ;

Grimm, Amandine ;

Eckert, Anne .

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2019, 2019

← 1 2 3 4 5 6 7 8 →